84 related articles for article (PubMed ID: 20409231)
21. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
22. Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway is essential for neuroendocrine differentiation of prostate cancer.
Wu C; Huang J
J Biol Chem; 2007 Feb; 282(6):3571-83. PubMed ID: 17148458
[TBL] [Abstract][Full Text] [Related]
23. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer.
Chen X; Thakkar H; Tyan F; Gim S; Robinson H; Lee C; Pandey SK; Nwokorie C; Onwudiwe N; Srivastava RK
Oncogene; 2001 Sep; 20(42):6073-83. PubMed ID: 11593415
[TBL] [Abstract][Full Text] [Related]
24. Adipocyte-derived monocyte chemotactic protein-1 (MCP-1) promotes prostate cancer progression through the induction of MMP-2 activity.
Ito Y; Ishiguro H; Kobayashi N; Hasumi H; Watanabe M; Yao M; Uemura H
Prostate; 2015 Jul; 75(10):1009-19. PubMed ID: 25917126
[TBL] [Abstract][Full Text] [Related]
25. Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/β-catenin signaling in prostate cancer cells.
Ciarlo M; Benelli R; Barbieri O; Minghelli S; Barboro P; Balbi C; Ferrari N
Int J Cancer; 2012 Aug; 131(3):582-90. PubMed ID: 22015967
[TBL] [Abstract][Full Text] [Related]
26. AKR1C2 and AKR1C3 mediated prostaglandin D2 metabolism augments the PI3K/Akt proliferative signaling pathway in human prostate cancer cells.
Wang S; Yang Q; Fung KM; Lin HK
Mol Cell Endocrinol; 2008 Jul; 289(1-2):60-6. PubMed ID: 18508192
[TBL] [Abstract][Full Text] [Related]
27. Ursolic Acid Induces Apoptosis of Prostate Cancer Cells via the PI3K/Akt/mTOR Pathway.
Meng Y; Lin ZM; Ge N; Zhang DL; Huang J; Kong F
Am J Chin Med; 2015; 43(7):1471-86. PubMed ID: 26503559
[TBL] [Abstract][Full Text] [Related]
28. EGFR signaling pathway negatively regulates PSA expression and secretion via the PI3K-Akt pathway in LNCaP prostate cancer cells.
Hakariya T; Shida Y; Sakai H; Kanetake H; Igawa T
Biochem Biophys Res Commun; 2006 Mar; 342(1):92-100. PubMed ID: 16472761
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of phosphatidylinositol-3/Akt-kinase inhibition on apoptotic sensitization to cytokines in LNCaP and PCc-3 prostate cancer cells.
Beresford SA; Davies MA; Gallick GE; Donato NJ
J Interferon Cytokine Res; 2001 May; 21(5):313-22. PubMed ID: 11429162
[TBL] [Abstract][Full Text] [Related]
30. Omental adipocytes enhance the invasiveness of gastric cancer cells by oleic acid-induced activation of the PI3K-Akt signaling pathway.
Xiang F; Wu K; Liu Y; Shi L; Wang D; Li G; Tao K; Wang G
Int J Biochem Cell Biol; 2017 Mar; 84():14-21. PubMed ID: 27956048
[TBL] [Abstract][Full Text] [Related]
31. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T
Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863
[TBL] [Abstract][Full Text] [Related]
32. In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis.
Chesire DR; Ewing CM; Gage WR; Isaacs WB
Oncogene; 2002 Apr; 21(17):2679-94. PubMed ID: 11965541
[TBL] [Abstract][Full Text] [Related]
33. Sinodielide A exerts thermosensitizing effects and induces apoptosis and G2/M cell cycle arrest in DU145 human prostate cancer cells via the Ras/Raf/MAPK and PI3K/Akt signaling pathways.
Hatashita M; Taniguchi M; Baba K; Koshiba K; Sato T; Jujo Y; Suzuki R; Hayashi S
Int J Mol Med; 2014 Feb; 33(2):406-14. PubMed ID: 24285252
[TBL] [Abstract][Full Text] [Related]
34. Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state.
Murillo H; Huang H; Schmidt LJ; Smith DI; Tindall DJ
Endocrinology; 2001 Nov; 142(11):4795-805. PubMed ID: 11606446
[TBL] [Abstract][Full Text] [Related]
35. Prostate cancer cell growth is modulated by adipocyte-cancer cell interaction.
Tokuda Y; Satoh Y; Fujiyama C; Toda S; Sugihara H; Masaki Z
BJU Int; 2003 May; 91(7):716-20. PubMed ID: 12699491
[TBL] [Abstract][Full Text] [Related]
36. Prostate cancer cell-adipocyte interaction: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase.
Onuma M; Bub JD; Rummel TL; Iwamoto Y
J Biol Chem; 2003 Oct; 278(43):42660-7. PubMed ID: 12902351
[TBL] [Abstract][Full Text] [Related]
37. Subcutaneous adipocytes promote melanoma cell growth by activating the Akt signaling pathway: role of palmitic acid.
Kwan HY; Fu X; Liu B; Chao X; Chan CL; Cao H; Su T; Tse AKW; Fong WF; Yu ZL
J Biol Chem; 2014 Oct; 289(44):30525-30537. PubMed ID: 25228694
[TBL] [Abstract][Full Text] [Related]
38. A new human adipocyte model with PTEN haploinsufficiency.
Kässner F; Kirstein A; Händel N; Schmid GL; Landgraf K; Berthold A; Tannert A; Schaefer M; Wabitsch M; Kiess W; Körner A; Garten A
Adipocyte; 2020 Dec; 9(1):290-301. PubMed ID: 32579864
[TBL] [Abstract][Full Text] [Related]
39. δ-Tocopherol inhibits the development of prostate adenocarcinoma in prostate specific Pten-/- mice.
Wang H; Yang X; Liu A; Wang G; Bosland MC; Yang CS
Carcinogenesis; 2018 Feb; 39(2):158-169. PubMed ID: 29121168
[TBL] [Abstract][Full Text] [Related]
40. Adipocyte secreted factors enhance aggressiveness of prostate carcinoma cells.
Moreira Â; Pereira SS; Costa M; Morais T; Pinto A; Fernandes R; Monteiro MP
PLoS One; 2015; 10(4):e0123217. PubMed ID: 25928422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
